Novo Nordisk Reports Positive Phase 3 STEP Young Results for Semaglutide in Children With Obesity Novo Nordisk has announced the first results from the STEP Young Phase 3 trial evaluating once-weekly semaglutide in children aged 6 to under 12 years…
Exegenesis Bio and Modalis Partner to Advance MDL-201 Gene Therapy for Duchenne Muscular Dystrophy Exegenesis Bio and Modalis Therapeutics Corporation (TOKYO: 4883) have entered into a research collaboration and license agreement aimed at advancing MDL-201, an investigational therapeutic candidate being…
Kallisio Expands Patient Access Program for Stentra in Head and Neck Cancer Radiation Therapy Kallisio has announced an expanded patient access program designed to help people preparing for radiation therapy for head and neck cancer obtain Stentra, a custom-fit, 3D-printed…
InduPro Publishes Nature Study Defining New Proximity-Based Targets for Cancer Therapeutics InduPro, Inc., a biotechnology company developing novel therapeutics for cancer and autoimmune diseases through protein proximity biology, has announced the publication of new research in the peer-reviewed scientific journal…
Flatiron Health and NCCN Renew Collaboration to Expand Real-World Evidence Research in Oncology Flatiron Health, a leading healthtech company focused on improving cancer care and advancing oncology research through real-world data (RWD), has announced the renewal of its long-standing collaboration…
Lotus Neuro Launches to Advance Focused Ultrasound Drug Delivery for Neurological Diseases Lotus Neuro, a clinical-stage biotechnology company focused on combining focused ultrasound with therapeutic medicines to address focal neurological diseases, has announced its public launch. The company is developing…
restor3d Launches MyFit Digital Suite to Enhance Personalized Orthopedic Patient Experience restor3d, a leader in personalized 3D-printed orthopedic solutions, has announced the launch of MyFit by restor3d Digital Suite, a new patient engagement ecosystem designed to give patients greater visibility…
Agilent Technologies Announces Board Leadership Transition and Appointment of Glenn Boehnlein Agilent Technologies Inc. (NYSE: A) has announced a series of leadership changes to its board of directors, marking an important transition in the company’s governance structure. Koh Boon Hwee,…
Aptar Pharma and Aceso Therapeutics Collaborate to Advance Inhaled ASO Therapy for Cystic Fibrosis Aptar Pharma, a global provider of drug delivery, dosing, protection technologies and development services, has announced a new collaboration with Aceso Therapeutics, a biotechnology company focused…
Segal Trials Employees Join CISCRP Medical Heroes Appreci-A-Thon to Honor Clinical Research Participants and Professionals More than 90 employees from Segal Trials are participating in the 8th Annual Medical Heroes Appreci-A-Thon organized by the Center for Information and Study on…
Biocytogen and Qilu Pharmaceutical Enter Non-Exclusive Licensing Agreement for Fully Human VHH Antibody in Neuroscience Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (SSE: 688796; HKEX: 02315), a biotechnology company focused on the discovery and development of innovative antibody-based therapeutics, has entered into…
Huonslab Expands Intellectual Property Portfolio for HyDIFFUZE™ Platform to Advance Subcutaneous Biologic Drug Delivery Huonslab, the research and development subsidiary of Huons Global (KOSDAQ: 084110), has strengthened its position in the rapidly evolving biologics market by securing new intellectual property…